PCSK9 inhibitors in neurodegenerative disorders: mechanisms, therapeutic potential, and clinical implications
- DOI
- 10.1186/s40035-026-00568-y
- Published
- 2026-08-18
- Container
- Translational Neurodegeneration
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40035-026-00568-y,
title = {PCSK9 inhibitors in neurodegenerative disorders: mechanisms, therapeutic potential, and clinical implications},
author = {Jia Dong James Wang and Andrea York Tiang Teo and Bin Xiao and Yinxia Chao and Zhi Dong Zhou and Brendan Jen-Wei Tan and Ling-Ling Chan and Elvira Rosalie and Eng-King Tan},
year = {2026},
journal = {Translational Neurodegeneration},
doi = {10.1186/s40035-026-00568-y},
url = {https://doi.org/10.1186/s40035-026-00568-y}
}RIS
TY - JOUR TI - PCSK9 inhibitors in neurodegenerative disorders: mechanisms, therapeutic potential, and clinical implications AU - Jia Dong James Wang AU - Andrea York Tiang Teo AU - Bin Xiao AU - Yinxia Chao AU - Zhi Dong Zhou AU - Brendan Jen-Wei Tan AU - Ling-Ling Chan AU - Elvira Rosalie AU - Eng-King Tan PY - 2026 JO - Translational Neurodegeneration DO - 10.1186/s40035-026-00568-y UR - https://doi.org/10.1186/s40035-026-00568-y ER -
APA
Wang, J. D. J., Teo, A. Y. T., Xiao, B., Chao, Y., Zhou, Z. D., Tan, B. J., Chan, L., Rosalie, E., & Tan, E. (2026). PCSK9 inhibitors in neurodegenerative disorders: mechanisms, therapeutic potential, and clinical implications. Translational Neurodegeneration. https://doi.org/10.1186/s40035-026-00568-y
Source records
- crossref · retrieved 2026-09-27T04:04:46.499Z